Collegium Pharmaceutical, Inc. COLL Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s stock issuance proceeds?
- Collegium Pharmaceutical, Inc. (COLL) reported stock issuance proceeds of $394K in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s stock issuance proceeds changed year-over-year?
- Collegium Pharmaceutical, Inc.'s stock issuance proceeds decreased by 74.6% year-over-year, from $1.55M to $394K.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s stock issuance proceeds has grown at a -22.6% compound annual growth rate (CAGR), from $11.95M to $4.28M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.